710 related articles for article (PubMed ID: 24175782)
21. Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy.
Fan Z; Li J; Wang T; Xie Y; Fan T; Lin B; Ouyang T
Breast; 2013 Dec; 22(6):1161-5. PubMed ID: 24080493
[TBL] [Abstract][Full Text] [Related]
22. Triple negative breast cancer: A clinico-epidemiological and histopronostic study of 90 cases.
Darouich S; El Amine El Hadj O; Betaieb I; Goucha A; Dhiab T; Rahal K; Gamoudi A; El May A
Tunis Med; 2017 Jan; 95(1):37-44. PubMed ID: 29327767
[TBL] [Abstract][Full Text] [Related]
23. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
24. Triple-Negative Breast Cancer in Ghanaian Women: The Korle Bu Teaching Hospital Experience.
Der EM; Gyasi RK; Tettey Y; Edusei L; Bayor MT; Jiagge E; Gyakobo M; Merajver SD; Newman LA
Breast J; 2015; 21(6):627-33. PubMed ID: 26547900
[TBL] [Abstract][Full Text] [Related]
25. The sensitivity of pre-operative axillary staging in breast cancer: comparison of invasive lobular and ductal carcinoma.
Topps A; Clay V; Absar M; Howe M; Lim Y; Johnson R; Bundred N
Eur J Surg Oncol; 2014 Jul; 40(7):813-7. PubMed ID: 24797703
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Local and Distant Recurrence Patterns in Patients with Triple-Negative Breast Cancer According to Age.
Radosa JC; Eaton A; Stempel M; Khander A; Liedtke C; Solomayer EF; Karsten M; Pilewskie M; Morrow M; King TA
Ann Surg Oncol; 2017 Mar; 24(3):698-704. PubMed ID: 27783163
[TBL] [Abstract][Full Text] [Related]
27. Retrospective analysis of clinicopathological factors and outcome in breast cancer in young women in a tertiary care hospital in India.
Deshmukh SP; Mane AD; Zade BP; Sane SP
Indian J Cancer; 2014; 51(4):594-8. PubMed ID: 26842207
[TBL] [Abstract][Full Text] [Related]
28. Does a Positive Axillary Lymph Node Needle Biopsy Result Predict the Need for an Axillary Lymph Node Dissection in Clinically Node-Negative Breast Cancer Patients in the ACOSOG Z0011 Era?
Pilewskie M; Mautner SK; Stempel M; Eaton A; Morrow M
Ann Surg Oncol; 2016 Apr; 23(4):1123-8. PubMed ID: 26553439
[TBL] [Abstract][Full Text] [Related]
29. [Breast cancer in women thirty years old or less].
Bakkali H; Marchal C; Lesur-Schwander A; Verhaeghe JL
Cancer Radiother; 2003 Jun; 7(3):153-9. PubMed ID: 12834769
[TBL] [Abstract][Full Text] [Related]
30. Prognosis for mammographically occult, early-stage breast cancer patients treated with breast-conservation therapy.
Yang TJ; Yang Q; Haffty BG; Moran MS
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):79-84. PubMed ID: 19619957
[TBL] [Abstract][Full Text] [Related]
31. Young breast cancer: A single center experience.
Gogia A; Raina V; Deo SV; Shukla NK; Mohanti BK
Indian J Cancer; 2014; 51(4):604-8. PubMed ID: 26842210
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical Profile of Breast Cancer Patients at a Tertiary Care Hospital in New Delhi, India.
Doval DC; Sharma A; Sinha R; Kumar K; Dewan AK; Chaturvedi H; Batra U; Talwar V; Gupta SK; Singh S; Bhole V; Mehta A
Asian Pac J Cancer Prev; 2015; 16(12):4959-64. PubMed ID: 26163622
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of Triple-Negative Breast Cancers (TNBC) Compared with Non-TNBC: Does the Survival Vary for All Stages?
Agarwal G; Nanda G; Lal P; Mishra A; Agarwal A; Agrawal V; Krishnani N
World J Surg; 2016 Jun; 40(6):1362-72. PubMed ID: 26842691
[TBL] [Abstract][Full Text] [Related]
34. Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.
Bonsang-Kitzis H; Chaltier L; Belin L; Savignoni A; Rouzier R; Sablin MP; Lerebours F; Bidard FC; Cottu P; Sastre-Garau X; Laé M; Pierga JY; Reyal F
PLoS One; 2015; 10(12):e0144359. PubMed ID: 26684197
[TBL] [Abstract][Full Text] [Related]
35. Breast carcinoma in women 35 years and younger: a pathological study.
Fernandopulle SM; Cher-Siangang P; Tan PH
Pathology; 2006 Jun; 38(3):219-22. PubMed ID: 16753742
[TBL] [Abstract][Full Text] [Related]
36. Breast cancer in women aging 35 years old and younger: The Egyptian National Cancer Institute (NCI) experience.
Darwish AD; Helal AM; Aly El-Din NH; Solaiman LL; Amin A
Breast; 2017 Feb; 31():1-8. PubMed ID: 27771499
[TBL] [Abstract][Full Text] [Related]
37. The effect of Paget disease on axillary lymph node metastases and survival in invasive ductal carcinoma.
Wong SM; Freedman RA; Sagara Y; Stamell EF; Desantis SD; Barry WT; Golshan M
Cancer; 2015 Dec; 121(24):4333-40. PubMed ID: 26376021
[TBL] [Abstract][Full Text] [Related]
38. [Clinical and pathological features of breast cancer in a population of Mexico].
Maffuz-Aziz A; Labastida-Almendaro S; Espejo-Fonseca A; Rodríguez-Cuevas S
Cir Cir; 2017; 85(3):201-207. PubMed ID: 27658545
[TBL] [Abstract][Full Text] [Related]
39. Axillary tumour burden in women with a fine-needle aspiration/core biopsy-proven positive node on ultrasonography compared to women with a positive sentinel node.
Lloyd P; Theophilidou E; Newcombe RG; Pugh L; Goyal A
Br J Surg; 2017 Dec; 104(13):1811-1815. PubMed ID: 28991362
[TBL] [Abstract][Full Text] [Related]
40. Standard Pathologic Features Can Be Used to Identify a Subset of Estrogen Receptor-Positive, HER2 Negative Patients Likely to Benefit from Neoadjuvant Chemotherapy.
Petruolo OA; Pilewskie M; Patil S; Barrio AV; Stempel M; Wen HY; Morrow M
Ann Surg Oncol; 2017 Sep; 24(9):2556-2562. PubMed ID: 28560596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
